Category: COMET-ICE trial

  • Vir and GSK Report Results of VIR-7831 in P-III COMET-ICE Trial for COVID-19

    Shots: The IDMC has recommended stopping the enrollment in the P-III COMET-ICE trial due to evidence of profound efficacy. The study involves assessing VIR-7831 (GSK4182136) vs PBO in 583 patients for the early treatment of COVID-19 in adults at high risk of hospitalization The results demonstrated an 85% reduction in hospitalization or death and were […]